GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
- Aortic Arch Dissection
- Aortic Arch Aneurysm
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- W.L.Gore & Associates
- Enrolment target
- 125
- Started
- 2 March 2026
- Main results due
- July 2028
- Study sites
- 19
- Registry updated
- 25 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: 1. Patient or legally authorized representative (LAR) provides written authorization and/or consent per institution and geographical requirements. 2. Patient has been or is intended to be treated with the TBE Device in Zone 0 or Zone 1. 3. Patient is age ≥ 18 years at time of informed consent signature. Exclusion Criteria: 1. Patient who is, at the time of consent, unlikely to be available for defined follow-up visits. 2. Patient with exclusion criteria required by local law. 3. Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or investigational device study within 12 months of study enrollment. Subjects cannot be enrolled in another Gore study.
What this study is about
In the sponsor’s own words, from the registry.
A prospective multi-center post-market study collecting outcomes through at least 5-years and up to 10-years post procedure for subjects treated with the TBE Device in Zone 0/1 as part of routine clinical practice.
Study sites(19)
HonorHealth
Scottsdale, Arizona, United States
Recruiting
Keck Medical Center of USC
Los Angeles, California, United States
Recruiting
University of California Davis Health System
Sacramento, California, United States
Recruiting
Hartford Hospital
Hartford, Connecticut, United States
Recruiting
MedStar Washington Hospital Center
Washington D.C., District of Columbia, United States
Recruiting
University of Florida Health Heart & Vascular
Gainesville, Florida, United States
Recruiting
Lakeland Regional Medical Center
Lakeland, Florida, United States
Recruiting
University of South Florida
Tampa, Florida, United States
Recruiting
Johns Hopkins University
Baltimore, Maryland, United States
Recruiting
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Recruiting
Duke University Medical Center
Durham, North Carolina, United States
Recruiting
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Recruiting
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
Recruiting
The Methodist Hospital-Houston
Houston, Texas, United States
Recruiting
Baylor Scott & White Research Institute
Plano, Texas, United States
Recruiting
Intermountain Medical Center
Murray, Utah, United States
Recruiting
University of Washington Medical Center
Seattle, Washington, United States
Recruiting
University of Wisconsin - Madison
Madison, Wisconsin, United States
Recruiting
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Recruiting
Showing 19 of 19 sites. 19 of the 19 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07166133. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me